Cargando…

Alternative Splicing Changes Promoted by NOVA2 Upregulation in Endothelial Cells and Relevance for Gastric Cancer

Angiogenesis is crucial for cancer progression. While several anti-angiogenic drugs are in use for cancer treatment, their clinical benefits are unsatisfactory. Thus, a deeper understanding of the mechanisms sustaining cancer vessel growth is fundamental to identify novel biomarkers and therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Matteo, Anna, Belloni, Elisa, Pradella, Davide, Chiaravalli, Anna Maria, Pini, Giacomo Maria, Bugatti, Mattia, Alfieri, Roberta, Barzan, Chiara, Franganillo Tena, Elena, Bione, Silvia, Terenzani, Elisa, Sessa, Fausto, Wyatt, Christopher D. R., Vermi, William, Ghigna, Claudia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10178952/ https://www.ncbi.nlm.nih.gov/pubmed/37175811 http://dx.doi.org/10.3390/ijms24098102

Ejemplares similares

Gene Expression Profiles Controlled by the Alternative Splicing Factor Nova2 in Endothelial Cells
por: Belloni, Elisa, et al.
Publicado: (2019)

The alternative splicing factor Nova2 regulates vascular development and lumen formation
por: Giampietro, Costanza, et al.
Publicado: (2015)

Alternative splicing in endothelial cells: novel therapeutic opportunities in cancer angiogenesis
por: Di Matteo, Anna, et al.
Publicado: (2020)

A ligand-insensitive UNC5B splicing isoform regulates angiogenesis by promoting apoptosis
por: Pradella, Davide, et al.
Publicado: (2021)

A novel L1CAM isoform with angiogenic activity generated by NOVA2-mediated alternative splicing
por: Angiolini, Francesca, et al.
Publicado: (2019)

SAM68: Signal Transduction and RNA Metabolism in Human Cancer
por: Frisone, Paola, et al.
Publicado: (2015)

EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression
por: Pradella, Davide, et al.
Publicado: (2017)

Upregulation of the alternative splicing factor NOVA2 in colorectal cancer vasculature
por: Gallo, Stefania, et al.
Publicado: (2018)

Evolution of Nova-Dependent Splicing Regulation in the Brain
por: Jelen, Nejc, et al.
Publicado: (2007)

Clinical Significance and Regulation of ERK5 Expression and Function in Cancer
por: Monti, Matilde, et al.
Publicado: (2022)

Global Alternative Splicing Defects in Human Breast Cancer Cells
por: Oh, Jagyeong, et al.
Publicado: (2021)

Opposite Roles of Tra2β and SRSF9 in the v10 Exon Splicing of CD44
por: Oh, Jagyeong, et al.
Publicado: (2020)

Alternative Splicing: Recent Insights into Mechanisms and Functional Roles
por: Ghigna, Claudia, et al.
Publicado: (2020)

The Neuronal Splicing Factor Nova Co-Localizes with Target RNAs in the Dendrite
por: Racca, Claudia, et al.
Publicado: (2010)

Human Plasmacytoid Dendritic Cells and Cutaneous Melanoma
por: Monti, Matilde, et al.
Publicado: (2020)

slan/M-DC8(+) cells constitute a distinct subset of dendritic cells in human tonsils
por: Micheletti, Alessandra, et al.
Publicado: (2015)

Correction: slan/M-DC8+ cells constitute a distinct subset of dendritic cells in human tonsils
por: Micheletti, Alessandra, et al.
Publicado: (2016)

Widespread Alternative Splicing Changes in Metastatic Breast Cancer Cells
por: Oh, Jagyeong, et al.
Publicado: (2021)

Nova1 is a master regulator of alternative splicing in pancreatic beta cells
por: Villate, Olatz, et al.
Publicado: (2014)

Alternative Splicing by NOVA Factors: From Gene Expression to Cell Physiology and Pathology
por: Meldolesi, Jacopo
Publicado: (2020)

Correction to: Evaluation of global and intragenic hypomethylation in colorectal adenomas improves patient stratification and colorectal cancer risk prediction
por: Debernardi, Carla, et al.
Publicado: (2021)

Evaluation of global and intragenic hypomethylation in colorectal adenomas improves patient stratification and colorectal cancer risk prediction
por: Debernardi, Carla, et al.
Publicado: (2021)

Alternative Splicing and Tumor Progression
por: Ghigna, Claudia, et al.
Publicado: (2008)

EBV(+) and MSI Gastric Cancers Harbor High PD-L1/PD-1 Expression and High CD8(+) Intratumoral Lymphocytes
por: De Rosa, Simona, et al.
Publicado: (2018)

slanDCs in carcinoma-draining lymph nodes
por: Vermi, William, et al.
Publicado: (2014)

Protective anti-tumor vaccination against glioblastoma expressing the MHC class II transactivator CIITA
por: Celesti, Fabrizio, et al.
Publicado: (2023)

Alternative Splicing: Role in Cancer Development and Progression
por: Sette, Claudio, et al.
Publicado: (2013)

Classical novae
por: Bode, Michael F, et al.
Publicado: (2008)

Nova and Glance
por: Rodrigues Moreira, Belmiro
Publicado: (2013)

Super nova
por: Shorter, Wayne
Publicado: (1988)

Nova express
por: Burroughs, William S., 1914-1997
Publicado: (1977)

Vita nova /
por: Dante Alighieri, 1265-1321
Publicado: (1947)

Cosmologia nova
por: Chechelnitsky, Albert M
Publicado: (2008)

Novae news
Publicado: (2012)

TLR Signalling Pathways Diverge in Their Ability to Induce PGE(2)
por: Salvi, Valentina, et al.
Publicado: (2016)

Self-Renewal of Macrophages: Tumor-Released Factors and Signaling Pathways
por: Filiberti, Serena, et al.
Publicado: (2022)

De novo truncating NOVA2 variants affect alternative splicing and lead to heterogeneous neurodevelopmental phenotypes
por: Scala, Marcello, et al.
Publicado: (2022)

NOVA regulates Dcc alternative splicing during neuronal migration and axon guidance in the spinal cord
por: Leggere, Janelle C, et al.
Publicado: (2016)

Aberrant NOVA1 function disrupts alternative splicing in early stages of amyotrophic lateral sclerosis
por: Krach, Florian, et al.
Publicado: (2022)

Nova proteins direct synaptic integration of somatostatin interneurons through activity-dependent alternative splicing
por: Ibrahim, Leena Ali, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_91rkb2qpu64ptjh6nqjnck2914